TLR-4:对于化疗诱导的外周神经病变来说是一个有希望的目标
Nagendra Babu1, Anagha Gadepalli1, Akhilesh1
1Neuroscience and Pain Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, India.
Molecular biology reports
|October 28, 2024
概括
化疗诱导的周围神经病变 (CIPN) 影响了许多癌症患者. 准类似收费受体-4 (TLR-4) 显示出通过解决神经炎症来治疗这种疾病的希望.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 是癌症患者常见的剂量限制副作用,影响治疗疗效.
- 目前对CIPN病原和有效的药理干预措施的理解仍然有限,这阻碍了临床试验的成功.
- 神经炎症越来越被认为是慢性疼痛疾病 (包括神经病痛) 的关键因素.
研究的目的:
- 审查收费类受体-4 (TLR-4) 作为CIPN.的治疗点的潜在作用.
- 分析涉及TLR-4,免疫细胞和CIPN发育中的信号通路的复杂相互作用.
- 为管理CIPN.提供有关新型治疗策略的见解.
主要方法:
- 文献综述侧重于疼痛研究,神经炎症和TLR-4.
- 对TLR-4在免疫反应和神经病痛中的作用现有研究的分析.
- 在CIPN的背景下探索TLR-4,免疫细胞和下游信号之间的相互作用.
主要成果:
- 收费类受体-4 (TLR-4) 是一种关键的免疫系统激活剂,对神经病痛有重大影响.
- 有证据表明,TLR-4在CIPN的发展和进展中起着核心作用.
- 由TLR-4激活的复杂的免疫细胞和通路网络有助于CIPN病理.
结论:
- TLR-4是缓解化疗诱导的外围神经病变的有希望的治疗标.
- 准TLR-4通路可能会导致新的治疗方法来缓解CIPN.
- 对TLR-4的作用进行进一步的研究可能会为管理这种令人衰弱的副作用提供开创性的方法.
更多相关视频
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
9.5K
03:26Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
2.4K
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
149
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
149
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K